[Results of a study of a live intranasal influenza vaccine in the immunization of children 3 to 15 years old].
A total of 10,971 children aged 3-15 years were immunized with live influenza vaccine (the variant intended for children), type A (H1N1). The vaccine proved to be nonreactogenic and produced no harmful effect on the child organism. The genetic stability of the vaccine strain and its high immunogenic activity were shown.
Rudenko
L G
LG
Grigor'eva
E P
EP
Drinevskiĭ
V P
VP
Koval'
T A
TA
Doroshenko
E M
EM
D000281:Administration, Intranasal; D000293:Adolescent; D000914:Antibodies, Viral / Q000032:analysis; D002648:Child; D002675:Child, Preschool; D004341:Drug Evaluation; D006801:Humans; D007114:Immunization / Q000379:methods*; D009980:Influenza A virus / Q000276:immunology; D007252:Influenza Vaccines / Q000008:administration & dosage* / Q000009:adverse effects / Q000276:immunology; D007251:Influenza, Human / Q000453:epidemiology / Q000517:prevention & control; D010919:Placebos; D012426:Russia; D014505:Urban Population
D000914:Antibodies, Viral; D007252:Influenza Vaccines; D010919:Placebos
Itogi izucheniia zhivoĭ grippoznoĭ intranazal'noĭ vaktsiny pri immunizatsii deteĭ 3--15 let.